- Home
- EDSA vs SLAI Comparison
EDSA vs SLAI Comparison
Compare EDSA & SLAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
SLAI
SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)
Current Price
Company Overview
Basic Information| Metric | EDSA | SLAI |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 12.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EDSA | SLAI |
|---|---|---|
| Price | $1.48 | $1.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | 47.0K | ★ 929.1K |
| Earning Date | 02-13-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $24,209,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.28 | $0.63 |
| 52 Week High | $4.49 | $8.07 |
Technical Indicators
Market Signals| Indicator | EDSA | SLAI |
|---|---|---|
| Relative Strength Index (RSI) | 41.95 | N/A |
| Support Level | $1.44 | N/A |
| Resistance Level | $1.57 | N/A |
| Average True Range (ATR) | 0.10 | 0.00 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 55.88 | 0.00 |
Price Performance
Historical ComparisonAbout EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.
About SLAI SOLAI Limited American Depositary Shares (each representing one hundred (100) Class A Ordinary Shares)
SOLAI Ltd is a technology-driven cryptocurrency infrastructure company. It is expanding from its foundation in crypto mining to build a blockchain-based ecosystem spanning AI, stablecoins, and payment infrastructure, and Solana treasury and staking operations supporting use cases across institutional settlement, commerce, consumer payments, and AI-native agent transactions. The group is leveraging its blockchain and data infrastructure expertise, aiming to enhance on-chain efficiency and expand participation across Solana and other blockchain ecosystems.